A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Pfizer Inc stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 221,251 shares of PFE stock, worth $6.56 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
221,251
Previous 224,651 1.51%
Holding current value
$6.56 Million
Previous $6.23 Million 0.71%
% of portfolio
0.51%
Previous 0.53%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$25.26 - $29.6 $85,884 - $100,640
-3,400 Reduced 1.51%
221,251 $6.19 Million
Q4 2023

Jan 31, 2024

BUY
$26.13 - $33.94 $154,794 - $201,060
5,924 Added 2.71%
224,651 $6.47 Million
Q3 2023

Oct 20, 2023

SELL
$32.09 - $37.51 $320,900 - $375,100
-10,000 Reduced 4.37%
218,727 $7.26 Million
Q2 2023

Jul 06, 2023

SELL
$36.12 - $41.79 $819,924 - $948,633
-22,700 Reduced 9.03%
228,727 $8.39 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $1.65 Million - $2.15 Million
-42,000 Reduced 14.31%
251,427 $10.3 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $3.39 Million - $4.13 Million
-77,400 Reduced 20.87%
293,427 $12.8 Million
Q2 2022

Aug 16, 2022

SELL
$46.53 - $55.17 $916,641 - $1.09 Million
-19,700 Reduced 5.04%
370,827 $19.4 Million
Q1 2022

Jun 21, 2022

BUY
$45.75 - $56.69 $164,700 - $204,084
3,600 Added 0.93%
390,527 $20.2 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $1.06 Million - $1.57 Million
-25,700 Reduced 6.23%
386,927 $22.8 Million
Q3 2021

Oct 28, 2021

SELL
$39.25 - $50.42 $502,400 - $645,376
-12,800 Reduced 3.01%
412,627 $17.7 Million
Q2 2021

Jul 13, 2021

BUY
$35.91 - $40.68 $1.02 Million - $1.16 Million
28,500 Added 7.18%
425,427 $16.7 Million
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $1.64 Million - $1.85 Million
49,100 Added 14.12%
396,927 $14.4 Million
Q4 2020

Mar 02, 2021

BUY
$33.47 - $42.56 $753,075 - $957,600
22,500 Added 6.92%
347,827 $12.8 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $184,150 - $216,050
-5,800 Reduced 1.75%
325,327 $11.9 Million
Q2 2020

Jul 08, 2020

BUY
$30.12 - $36.54 $99,396 - $120,582
3,300 Added 1.01%
331,127 $10.8 Million
Q1 2020

Apr 22, 2020

BUY
$27.03 - $38.62 $391,935 - $559,990
14,500 Added 4.63%
327,827 $10.7 Million
Q4 2019

Jan 28, 2020

SELL
$32.92 - $37.36 $661,692 - $750,936
-20,100 Reduced 6.03%
313,327 $12.3 Million
Q2 2019

Jul 19, 2019

BUY
$36.98 - $41.52 $310,632 - $348,768
8,400 Added 2.58%
333,427 $14.4 Million
Q1 2019

May 09, 2019

BUY
$37.5 - $41.2 $93,750 - $103,000
2,500 Added 0.78%
325,027 $13.8 Million
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $76,940 - $87,720
2,000 Added 0.62%
322,527 $14.1 Million
Q3 2018

Oct 26, 2018

SELL
$34.47 - $41.81 $3.65 Million - $4.42 Million
-105,800 Reduced 24.82%
320,527 $14.1 Million
Q2 2018

Jul 10, 2018

BUY
$32.98 - $35.16 $474,911 - $506,303
14,400 Added 3.5%
426,327 $15.5 Million
Q1 2018

Apr 11, 2018

BUY
$31.91 - $37.02 $462,695 - $536,790
14,500 Added 3.65%
411,927 $13.3 Million
Q4 2017

Jan 18, 2018

SELL
$33.26 - $35.29 $731,720 - $776,380
-22,000 Reduced 5.25%
397,427 $14.4 Million
Q3 2017

Oct 12, 2017

BUY
$31.0 - $34.15 $13 Million - $14.3 Million
419,427
419,427 $15 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Livforsakringsbolaget Skandia, Omsesidigt Portfolio

Follow Livforsakringsbolaget Skandia, Omsesidigt and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.